Seven Bridges Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,037
Closed -$239K 155
2016
Q3
$239K Sell
1,037
-2,703
-72% -$661K 0.21% 94
2016
Q2
$864K Sell
3,740
-153
-4% -$35.3K 0.74% 39
2016
Q1
$1.04M Sell
3,893
-517
-12% -$148K 0.82% 37
2015
Q4
$1.38M Buy
+4,410
New +$1.31M 1.38% 18

Other funds holding AGN

Seven Bridges Advisors's AGN Position: Q4 2016 in Review

Seven Bridges Advisors sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 1,037 shares — an estimated $239K sold.

Seven Bridges Advisors first reported a position in AGN in Q4 2015 and held it in 4 quarters. The position peaked at $1.38M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Seven Bridges Advisors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Seven Bridges Advisors sold 1,037 Allergan plc shares in Q4 2016, an estimated $239K.
  • Seven Bridges Advisors first reported a position in Allergan plc in Q4 2015 and held it in 4 quarters.
  • Seven Bridges Advisors's Allergan plc position peaked at $1.38M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Seven Bridges Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.